Market News (Page 12) - TendieTensor

Market News Page 12 of 292 • 7,279 articles

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

GlobeNewswire Inc. • Nvidia Corporation

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

01/12/2026 10:00 AM • NVIDIA announced a major expansion of its BioNeMo platform for AI-driven drug discovery, including new models for RNA structure prediction and drug synthesis. The company launched landmark collaborations with Eli Lilly on a co-innovation lab with up to $1 billion investment over five years, and with Thermo Fisher to build autonomous lab infrastructure. A growing ecosystem of biotech companies are adopting BioNeMo for AI-driven molecular design and drug discovery.

GSK - Acquiring rights to relaunch BREXAFEMME with potential market opportunity
NVDA - NVIDIA is expanding its BioNeMo platform with new capabilities, securing major partnerships with leading pharmaceutical and life sciences companies, and positioning itself as the central AI infrastructure provider for drug discovery. The $1 billion Lilly investment and Thermo Fisher collaboration demonstrate strong market validation and revenue growth potential.

#AI drug discovery #BioNeMo platform #autonomous laboratories #pharmaceutical innovation #accelerated computing #molecular design #foundation models #lab automation

Ditch the Resolutions, Keep the Savings: Denny’s Launches NEW Slammin’ Meal Deals Starting at $5.99

GlobeNewswire Inc. • Denny'S Media Team

Ditch the Resolutions, Keep the Savings: Denny’s Launches NEW Slammin’ Meal Deals Starting at $5.99

01/12/2026 10:00 AM • Denny's launched a new Slammin' Meal Deals value menu starting at $5.99 featuring full breakfast, lunch, and dinner meals, along with the return of guest-favorite Salted Caramel Banana Slams and new Mocha Cold Brew options. The campaign targets 'Quitter's Day' (January 12) when New Year's resolutions typically fail, positioning comfort food and value as alternatives to restrictive dieting.

DENN - The company is launching strategic menu innovations with a new value-focused offering at an attractive price point ($5.99), bringing back popular items, and expanding beverage options. The campaign demonstrates marketing agility by capitalizing on a cultural moment (Quitter's Day) and emphasizes value and customer rewards, which should drive traffic and customer retention during a traditionally weak period for restaurants.

#value menu #Quitter's Day #Salted Caramel Banana Slams #comfort food #family dining #Denny's Rewards #cold brew #meal deals

Black Rock Coffee Bar Continues Expansion in Colorado with New Colorado Springs Location

GlobeNewswire Inc. • Not Specified

Black Rock Coffee Bar Continues Expansion in Colorado with New Colorado Springs Location

01/12/2026 10:00 AM • Black Rock Coffee Bar, an Oregon-based boutique coffee company, is opening its third location in Colorado Springs on January 16, 2026. The expansion marks the beginning of the company's planned growth in the region throughout 2026. The new store will offer opening week specials and features the brand's specialty coffees, teas, smoothies, and Fuel energy drinks.

BRCB - The company is actively expanding its footprint with a new location marking its third in Colorado Springs, demonstrating business growth and market confidence. CEO commentary expresses optimism about future expansion plans in 2026, and the company reports positive community reception. The introduction of new menu items and loyalty program features indicates ongoing innovation and customer engagement initiatives.

#expansion #Colorado Springs #new location #coffee shop #opening week specials #Fuel energy drinks #Black Rock Rewards

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

GlobeNewswire Inc. • Na

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

01/12/2026 10:00 AM • NVIDIA and Eli Lilly announced a first-of-its-kind AI co-innovation lab to accelerate drug discovery and pharmaceutical manufacturing. The companies will invest up to $1 billion over five years in the San Francisco Bay Area facility, combining Lilly's pharmaceutical expertise with NVIDIA's AI and computing capabilities. The lab will focus on creating continuous learning systems connecting wet labs with computational resources, using NVIDIA's BioNeMo platform and Vera Rubin architecture to build advanced AI models for drug development.

NVDA - NVIDIA is positioned as a key technology partner providing critical AI infrastructure, computing platforms (BioNeMo, Vera Rubin), and expertise. The partnership validates NVIDIA's AI leadership in life sciences and expands its addressable market in pharmaceutical R&D, representing significant business opportunity and strategic positioning.

#AI co-innovation lab #drug discovery #pharmaceutical manufacturing #BioNeMo platform #foundation models #digital twins #robotics #accelerated computing

Global Utility Poles Market Set to Reach US$ 71.31 Billion by 2033 | Astute Analytica

GlobeNewswire Inc. • Astute Analytica

Global Utility Poles Market Set to Reach US$ 71.31 Billion by 2033 | Astute Analytica

01/12/2026 10:00 AM • The global utility poles market is projected to grow from US$ 47.45 billion in 2024 to US$ 71.31 billion by 2033 at a CAGR of 4.63%, driven by grid modernization, smart grid integration, and telecom expansion. Distribution poles command 47.4% market share, while energy transmission and distribution account for 79.4% of revenue. Europe is leading investments with major TSOs like TenneT and Elia Group committing billions to renewable energy integration and cross-border connectivity.

TECK - Referenced as having a past-producing mine near the exploration site, no direct operational impact
VMI - Listed as a key company in the utility poles market which is experiencing significant growth with projected CAGR of 4.63% through 2033, driven by grid modernization and infrastructure expansion.

#utility poles market #grid modernization #smart poles #5G infrastructure #renewable energy integration #distribution infrastructure #transmission poles #composite materials

What to Know About a $356,000 Perpetua Insider Stock Sale Amid a 145% Price Surge

The Motley Fool • Jonathan Ponciano

What to Know About a $356,000 Perpetua Insider Stock Sale Amid a 145% Price Surge

01/12/2026 09:33 AM • A director at Perpetua Resources sold 13,148 shares worth $356,192 on January 5-7, representing 44.57% of direct holdings. This was the director's first open-market sale following a 145% stock price surge over the past year. The sale stemmed from exercising options and likely reflects personal portfolio management rather than loss of conviction, as the company recently broke ground on its Stibnite Gold Project and secured over $380 million in equity financing.

PPTA - While the insider sale could signal profit-taking, the article emphasizes this is likely routine portfolio management from option exercise rather than a loss of confidence. The company's recent achievements (project groundbreaking, $380M+ financing, potential $2B debt financing) and transition to execution phase suggest positive fundamentals. The 145% price surge and strong capital position offset concerns about the insider sale.

#insider stock sale #option exercise #mineral exploration #gold mining #antimony #Stibnite Gold Project #equity financing #critical minerals

Will Quantum Computing Stocks Become the AI Stocks of 2026?

The Motley Fool • Adria Cimino

Will Quantum Computing Stocks Become the AI Stocks of 2026?

01/12/2026 09:32 AM • The article explores whether quantum computing stocks could drive market gains similar to AI stocks in 2026. While quantum computing pure plays like Rigetti Computing, D-Wave Quantum, and IonQ have surged significantly, the author concludes it's too early for quantum stocks to match AI's market impact, as quantum computing remains in earlier development stages compared to AI's current revenue-generating phase. However, progress in quantum computing could still benefit these stocks and related tech giants long-term.

RGTI - Stock has surged in quadruple digits over three years, but author notes it's too early for quantum stocks to drive overall market gains like AI stocks have done. Potential exists but remains speculative.

#quantum computing #AI stocks #market growth #technology investment #quantum computing stocks #pure play companies

Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve

Benzinga • Vandana Singh

Court Ruling Ends Edwards Lifesciences $1.2 Billion Plan To Acquire JenaValve

01/12/2026 09:31 AM • A U.S. District Court granted the FTC's motion to block Edwards Lifesciences' $1.2 billion acquisition of JenaValve Technology, citing concerns that the deal would eliminate competition in the TAVR-AR device market and potentially harm innovation and patient access. Despite the setback, Edwards raised its 2026 adjusted EPS guidance to $2.90-$3.05 and continues advancing its own transcatheter aortic regurgitation valve.

BIVIW - Company is advancing multiple late-stage clinical programs with promising drug candidates targeting significant medical conditions, showing strong safety data and potential for market expansion
EW - The company faced a significant setback with the blocked acquisition, which is negative. However, this was offset by raised 2026 EPS guidance and continued progress on its own SOJOURN transcatheter valve program, resulting in a neutral overall sentiment.

#acquisition blocked #FTC injunction #TAVR-AR devices #medical devices #competition #transcatheter valves #aortic regurgitation

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

GlobeNewswire Inc. • Not Specified

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

01/12/2026 09:00 AM • AOP Health US announced expanded distribution of Rapiblyk™ (landiolol), an FDA-approved ultra-short-acting beta-blocker for treating rapid heart rates in critical care settings. The drug is now available through four major pharmaceutical wholesalers: Cardinal, Cencora Specialty Distribution, McKesson Corporation, and Morris & Dickson, enhancing accessibility for hospitals and health systems nationwide.

SHOP - Mentioned in context of beta-testing Managed Markets flow without detailed performance information
CAH - Cardinal is mentioned as one of four distribution partners for Rapiblyk, representing routine business expansion but without specific financial impact or strategic significance disclosed in the article.

#Rapiblyk #landiolol #beta-blocker #supraventricular tachycardia #atrial fibrillation #critical care #pharmaceutical distribution #FDA approval

Grocery Outlet Enters Sixteenth State with Store Opening in Virginia

GlobeNewswire Inc. • Na

Grocery Outlet Enters Sixteenth State with Store Opening in Virginia

01/12/2026 09:00 AM • Grocery Outlet announced its official entrance into Virginia with the opening of its first store in Falls Church on February 12, 2026. The expansion marks a key milestone in the company's long-term growth strategy, with plans for additional openings across the state. The retailer offers products at 40-70% below conventional retail prices.

TPR - Noted as a new partner in UK and Europe without specific performance context
GO - The company is executing its disciplined growth strategy by entering a new state market (Virginia), expanding its footprint to over 560 stores nationwide. The announcement demonstrates operational progress and market expansion momentum, which are positive indicators for investor confidence and future revenue growth.

#store expansion #Virginia market entry #extreme value retail #growth strategy #discount grocery #Falls Church opening

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

GlobeNewswire Inc. • Na

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

01/12/2026 09:00 AM • SI-BONE announced preliminary Q4 2025 revenue of $56.2-$56.3 million (~15% growth) and full year 2025 revenue of $200.8-$200.9 million (~20% growth). The company reported ~1,640 active U.S. physicians (18% increase) and cash equivalents of ~$147.7 million with net cash generation of ~$2.0 million in Q4. Final audited results will be provided in late February 2026.

SIBN - The company demonstrated strong financial performance with 20% full-year revenue growth, 21% U.S. revenue growth, 18% physician growth, and positive cash generation. These metrics indicate healthy business expansion and market adoption of their procedural solutions.

#medical device #revenue growth #SI joint fusion #spinal deformity #pelvic trauma #physician adoption #cash generation #additive manufacturing

Channelscaler More than Doubles Year-Over-Year Pipeline Growth for Partners in 2025

GlobeNewswire Inc. • Not Specified

Channelscaler More than Doubles Year-Over-Year Pipeline Growth for Partners in 2025

01/12/2026 09:00 AM • Channelscaler, a partner relationship management platform formed from the 2024 merger of Allbound and Channel Mechanics, announced significant growth in 2025 including expanded leadership team appointments, recognition as a market leader in IDC's PRM software assessment, and new AI-driven tools for partner program automation. The company reported partners achieving up to 200% year-over-year pipeline growth.

CCL - Strong post-pandemic recovery, record bookings, reducing debt, improving credit ratings, and trading at low P/E ratio of less than 14
SAP - SAP is mentioned only as a customer using Channelscaler's platform; no specific information about SAP's performance or sentiment drivers is provided in the article.

#partner relationship management #AI innovation #leadership expansion #SaaS growth #channel partner ecosystem #market recognition #platform automation

Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System

GlobeNewswire Inc. • Not Specified

Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System

01/12/2026 09:00 AM • Distalmotion announced a strategic investment from Johnson & Johnson's venture capital arm (JJDC) to advance expansion of its DEXTER robotic surgery system in ambulatory surgery centers (ASCs). This follows the company's $150M Series G funding round in 2025. DEXTER, designed specifically for outpatient settings, has been cleared in the US for hernia repair, cholecystectomy, and benign hysterectomy procedures, with over 3,000 patients treated to date.

JNJ - Strategic investment in Distalmotion through JJDC demonstrates J&J's commitment to robotic surgery innovation and positioning in the growing outpatient surgery market, indicating confidence in the DEXTER platform's potential.

#robotic surgery #ambulatory surgery centers #DEXTER system #venture capital investment #minimally invasive surgery #medical technology #outpatient care

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

GlobeNewswire Inc. • Inspiremd, Inc.

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

01/12/2026 09:00 AM • InspireMD announced that its C-GUARDIANS pivotal trial results have been published in JACC, demonstrating that the CGuard® Prime Carotid Stent System achieved the lowest 30-day and 1-year major adverse event rates in carotid stenting studies, with a 30-day DSMI rate of 0.95% and 1-year ipsilateral stroke rate of 1.93%. The trial enrolled 316 patients including 25% symptomatic cases, showing strong safety and efficacy data for carotid artery stenosis treatment.

STZ - Down 40% in 2025 but with significant analyst price target upside, low forward earnings multiple, and diverse beverage portfolio
NSPR - The company announced positive pivotal trial results published in a top-tier medical journal (JACC), demonstrating superior safety outcomes (lowest event rates in the industry) for its flagship product CGuard® Prime. The publication in a prestigious journal and achievement of primary endpoints with historically low complication rates represent significant validation and should support future adoption and revenue growth.

#carotid stenting #CGuard Prime #clinical trial results #stroke prevention #FDA approval #medical device #interventional cardiology

Oriental Culture Holding LTD Announces Special Cash Dividend Plan to Reward Shareholders on Fifth Anniversary of Listing

Benzinga • Prnewswire

Oriental Culture Holding LTD Announces Special Cash Dividend Plan to Reward Shareholders on Fifth Anniversary of Listing

01/12/2026 08:55 AM • Oriental Culture Holding (NASDAQ: OCG) announced a special cash dividend of $0.05 per share to celebrate its fifth anniversary of listing on Nasdaq. The dividend will be paid on February 9, 2026, to shareholders of record as of January 22, 2026. CEO Shao Yi stated the company is returning accumulated cash reserves to shareholders as a reward for their long-term support and to foster long-term value creation.

OCG - The announcement of a special cash dividend demonstrates financial strength and management's commitment to returning value to shareholders. The dividend payment indicates the company has sufficient cash reserves after funding operations, which is a positive signal of financial health and confidence in the business.

#special cash dividend #fifth anniversary #shareholder reward #Nasdaq listing #cash reserves

LightPath Technologies to Participate in the 28th Annual Needham Growth Conference on January 15, 2026

Benzinga • Prnewswire

LightPath Technologies to Participate in the 28th Annual Needham Growth Conference on January 15, 2026

01/12/2026 08:31 AM • LightPath Technologies (NASDAQ:LPTH) announced it will participate in the 28th Annual Needham Growth Conference on January 15, 2026, hosting one-on-one virtual meetings with institutional investors. The company highlighted its strengthened balance sheet following a recent financing and plans to discuss its defense and commercial optics platforms and strategic priorities.

LPTH - The company is actively engaging with institutional investors at a major growth conference, recently completed successful financing, and management expressed confidence in advancing strategic priorities and creating shareholder value. The tone is optimistic about market opportunities and the company's strengthened financial position.

#LightPath Technologies #Needham Growth Conference #optics and imaging systems #defense applications #commercial applications #investor meetings #balance sheet #infrared optical systems

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

GlobeNewswire Inc. • Orion Corporation

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

01/12/2026 08:00 AM • BlackRock, Inc. and its funds have exceeded the 5% ownership threshold in Orion Corporation, reaching a combined 5.01% stake as of January 9, 2026. The holding consists of 4.97% in direct shares (7,014,577 shares) and 0.04% through financial instruments including American Depositary Receipts and borrowed securities.

NSRGY - Mentioned as the seller of the infant formula plant and brand rights, with no direct negative implications in the lawsuit
BLK - The disclosure is a regulatory announcement of BlackRock crossing the 5% ownership threshold in Orion. This is a factual reporting of shareholding changes with no inherent positive or negative implications. It represents a significant investment position but does not indicate strategic intent or market impact.

#major shareholder disclosure #ownership threshold #BlackRock #Orion Corporation #5% stake #financial instruments #Securities Market Act

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

GlobeNewswire Inc. • Na

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

01/12/2026 08:00 AM • MDxHealth reported preliminary 2025 revenues of $109 million (21% YoY growth) with Q4 revenues of $30.5 million (23% YoY growth). The company issued 2026 revenue guidance of $137-140 million (26-28% growth) and expects to achieve a 10% adjusted EBITDA margin run rate by year-end 2026. MDxHealth amended its earnout obligations with Exact Sciences, deferring payments to 2026-2028 and issuing 3 million warrant shares at $5.265 per share.

EXAS - Exact Sciences benefited from earnout amendment deferring payments and receiving 3 million warrant shares, providing liquidity relief to MDxHealth. The amendment is mutually beneficial but represents a restructuring of original acquisition terms rather than new positive developments.

#precision diagnostics #prostate cancer testing #revenue growth #2026 guidance #earnout amendment #liquid-based units #tissue-based units #EBITDA margin #GPS test #ExoDx

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

GlobeNewswire Inc. • Orion Corporation Communications

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

01/12/2026 08:00 AM • BlackRock, Inc. and its funds have crossed the 5% ownership threshold in Orion Corporation as of January 9, 2026, holding 5.01% of total shares and voting rights (7,014,577 direct shares plus 57,180 shares through financial instruments). This disclosure was made under Chapter 9, Section 10 of the Securities Market Act.

BLK - The disclosure is a factual regulatory announcement of BlackRock crossing the 5% ownership threshold in Orion. While this indicates significant investment interest, the announcement itself is neutral in tone and is a standard regulatory filing with no indication of positive or negative implications for either party.

#major shareholder disclosure #5% threshold #ownership stake #BlackRock #Orion Corporation #Securities Market Act #voting rights

U.S. Mental Health Treatment Market Report and Directory 2026, Profiles of Acadia, Universal Health Services, Lyra Health, Spring Health, Headspace, Calm, Talkspace, BetterHelp, Carelon

GlobeNewswire Inc. • Marketdata Llc

U.S. Mental Health Treatment Market Report and Directory 2026, Profiles of Acadia, Universal Health Services, Lyra Health, Spring Health, Headspace, Calm, Talkspace, BetterHelp, Carelon

01/12/2026 07:59 AM • The U.S. mental health treatment market is valued at $118 billion and is projected to grow significantly through 2030, driven by increased awareness, technology integration, and rising mental illness prevalence affecting 61 million Americans. The sector faces challenges including a shortage of mental health professionals and access gaps, while teletherapy and mental health apps have created a $2 billion market segment. Major players include facility operators like Acadia Healthcare and Universal Health Services, alongside digital platforms such as Lyra Health, Spring Health, Headspace, Calm, Talkspace, and BetterHelp.

ACHC - Identified as a major industry leader in facility operations with strong market position in the growing $118 billion mental health treatment market

#mental health market #teletherapy #mental health apps #behavioral health #therapist shortage #digital health platforms #psychiatric care

Transactions in connection with share buyback programme

GlobeNewswire Inc. • Netcompany Group A/S

Transactions in connection with share buyback programme

01/12/2026 07:56 AM • Netcompany Group A/S executed 66,000 share buybacks during the week of 5-9 January 2026 at an average price of DKK 361.99, bringing total accumulated buybacks to 1,443,896 shares worth DKK 411.1m. The company now holds 1,801,415 treasury shares (3.8% of share capital) following the transactions and vesting of restricted share units. The buyback programme, initiated on 14 August 2025 with a budget of DKK 500m and maximum 3.7m shares, will conclude by 30 January 2026.

NETGY - The share buyback programme is a routine capital management activity executed in compliance with regulations. The consistent execution of buybacks at stable prices (DKK 351-367 range) and progress toward programme targets indicates orderly, planned financial management. No material business developments or concerns are indicated, making this a neutral operational announcement.

#share buyback #treasury shares #capital structure #share-based incentive programmes #Market Abuse Regulation #Nasdaq Copenhagen

Global Catheters Market Size to Hit USD 55.58 Billion by 2033, Driven by Rising Cardiovascular and Urological Procedures – SNS Insider

GlobeNewswire Inc. • Sns Insider

Global Catheters Market Size to Hit USD 55.58 Billion by 2033, Driven by Rising Cardiovascular and Urological Procedures – SNS Insider

01/12/2026 07:52 AM • The global catheters market is projected to grow from USD 29.17 billion in 2025 to USD 55.58 billion by 2033, with a CAGR of 8.41%. Growth is driven by increasing cardiovascular and urological procedures, aging populations, and technological advancements. However, catheter-associated infections and antibiotic resistance pose challenges. North America dominates with 38.05% market share, while Asia Pacific is the fastest-growing region at 9.23% CAGR.

CPB - Stock down 26% in 2025, but shows potential bullish reversal with analyst price target suggesting upside
MDT - Company is advancing its APOLLO trial for the Intrepid TMVR device with over 2,500 patient enrollments, demonstrating active innovation and market expansion in transcatheter mitral valve replacement therapy.

#catheters market #cardiovascular procedures #urological procedures #minimally invasive procedures #medical devices #healthcare infrastructure #catheter-associated infections #antimicrobial coatings #silicone catheters #homecare settings

Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery

GlobeNewswire Inc. • Researchandmarkets.Com

Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery

01/12/2026 07:50 AM • A comprehensive market research report analyzing the convergence of Information and Communications Technology (ICT) and biomedical sciences through 2030. The report highlights opportunities in connected medical devices, precision medicine, and healthcare delivery optimization, driven by the need to address rising healthcare costs while improving patient outcomes through real-time monitoring and data-driven personalized treatments.

GIS - Strong baking season potential, parent of iconic brands like Pillsbury, trading at attractive 10x earnings with analyst price target indicating significant upside
ABT - Listed as a key company in the biomedical and ICT convergence market, positioned to benefit from growing demand for connected medical devices and diagnostic solutions.

#biomedical technology #ICT convergence #connected medical devices #precision medicine #healthcare delivery #IoT healthcare #wearable devices #telemedicine #personalized treatment #healthcare economics

Rumble Secures Exclusive Video and Live Streaming Rights for The Dan Bongino Show

GlobeNewswire Inc. • Not Specified

Rumble Secures Exclusive Video and Live Streaming Rights for The Dan Bongino Show

01/12/2026 07:47 AM • Rumble Inc. has secured an exclusive video and live streaming distribution agreement with The Dan Bongino Show, which will relaunch on February 2, 2026. The show will stream weekdays for two hours on Rumble exclusively, with audio versions available on major podcast platforms. Westwood One will handle advertising sales for the program.

MKC - Strongest revenue quarter historically, stable dividend with 38-year increase streak, attractive valuation with potential 21% upside
RUM - Rumble secured an exclusive high-profile content deal with a major media personality, strengthening its platform's content library and competitive positioning. The CEO highlighted this as marking 'a new era' for the platform ahead of the 2026 midterms, indicating strategic growth and increased user engagement potential.

#Rumble Inc. #Dan Bongino Show #exclusive distribution agreement #video streaming #podcasting #Westwood One #independent media

Valuation Implications of Domestic Rare Earth Supply Chain Reshoring Corporate Analysis Report 2025: MP Materials and Lynas Positioned for Growth Via Governmental Backing and Strategic Offtake Agreements

GlobeNewswire Inc. • Researchandmarkets.Com

Valuation Implications of Domestic Rare Earth Supply Chain Reshoring Corporate Analysis Report 2025: MP Materials and Lynas Positioned for Growth Via Governmental Backing and Strategic Offtake Agreements

01/12/2026 07:46 AM • A new market analysis report examines opportunities in reshoring rare earth supply chains to reduce Western dependency on China, which controls 85-90% of global refined production. The report identifies MP Materials and Lynas as key beneficiaries positioned for growth through government backing and strategic offtake agreements, with domestic suppliers potentially commanding 250-350% price premiums over Chinese benchmarks due to security considerations.

MKC.V - Strongest revenue quarter historically, stable dividend with 38-year increase streak, attractive valuation with potential 21% upside
MP - Identified as the leading U.S. rare earth producer with the only fully integrated U.S. mine-to-magnet operation at Mountain Pass. Positioned as a primary beneficiary of government backing, strategic offtake agreements with major customers (GM, Apple), and security premium valuations.

#rare earth elements #supply chain reshoring #geopolitical risk #domestic production #national security #China dependency #critical minerals #defense technology #green energy transition